DE69805909T2 - Fluorosubstituierte Adamantan-Derivate - Google Patents
Fluorosubstituierte Adamantan-DerivateInfo
- Publication number
- DE69805909T2 DE69805909T2 DE69805909T DE69805909T DE69805909T2 DE 69805909 T2 DE69805909 T2 DE 69805909T2 DE 69805909 T DE69805909 T DE 69805909T DE 69805909 T DE69805909 T DE 69805909T DE 69805909 T2 DE69805909 T2 DE 69805909T2
- Authority
- DE
- Germany
- Prior art keywords
- adamantane
- relates
- formula
- fluorosubstituted
- adamantane derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C211/34—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton
- C07C211/38—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton containing condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/24—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C61/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C61/15—Saturated compounds containing halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
- C07C69/757—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
- C07C2603/74—Adamantanes
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Virology (AREA)
- Psychology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4465897P | 1997-04-10 | 1997-04-10 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69805909D1 DE69805909D1 (de) | 2002-07-18 |
DE69805909T2 true DE69805909T2 (de) | 2002-09-26 |
Family
ID=21933590
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69805909T Expired - Fee Related DE69805909T2 (de) | 1997-04-10 | 1998-03-24 | Fluorosubstituierte Adamantan-Derivate |
Country Status (10)
Country | Link |
---|---|
US (1) | US6057364A (de) |
EP (1) | EP0870757B1 (de) |
JP (2) | JP2951313B2 (de) |
AT (1) | ATE219044T1 (de) |
BR (1) | BR9801157A (de) |
CA (1) | CA2234319C (de) |
DE (1) | DE69805909T2 (de) |
DK (1) | DK0870757T3 (de) |
ES (1) | ES2175614T3 (de) |
PT (1) | PT870757E (de) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6444702B1 (en) * | 2000-02-22 | 2002-09-03 | Neuromolecular, Inc. | Aminoadamantane derivatives as therapeutic agents |
JP2002040648A (ja) * | 2000-07-28 | 2002-02-06 | Sony Corp | 露光方法 |
US20040122090A1 (en) * | 2001-12-07 | 2004-06-24 | Lipton Stuart A. | Methods for treating neuropsychiatric disorders with nmda receptor antagonists |
US7795468B2 (en) * | 2001-01-19 | 2010-09-14 | Chevron U.S.A. Inc. | Functionalized higher diamondoids |
JPWO2005123650A1 (ja) * | 2004-06-16 | 2008-04-10 | 旭硝子株式会社 | 新規なフッ素化されたアダマンタン誘導体 |
JPWO2005123653A1 (ja) * | 2004-06-16 | 2008-04-10 | 旭硝子株式会社 | フルオロアダマンタン誘導体 |
US7619007B2 (en) | 2004-11-23 | 2009-11-17 | Adamas Pharmaceuticals, Inc. | Method and composition for administering an NMDA receptor antagonist to a subject |
WO2006121560A2 (en) | 2005-04-06 | 2006-11-16 | Adamas Pharmaceuticals, Inc. | Methods and compositions for treatment of cns disorders |
JP5073664B2 (ja) * | 2005-08-31 | 2012-11-14 | エフ.ホフマン−ラ ロシュ アーゲー | 11−βHSD1インヒビターとしてのピラゾロン誘導体 |
JP5132238B2 (ja) * | 2007-10-05 | 2013-01-30 | 国立大学法人北海道大学 | フッ素化アダマンタン化合物の製造方法 |
TWI432188B (zh) * | 2008-12-19 | 2014-04-01 | Merz Pharma Gmbh & Co Kgaa | 供治療發炎性皮膚疾病之1-胺基-烷基環己烷衍生物類 |
US8399519B2 (en) | 2008-12-19 | 2013-03-19 | Merz Pharma Gmbh & Co. Kgaa | 1-amino-alkylcyclohexane derivatives for the treatment of mast cell mediated diseases |
BR112012013487A2 (pt) | 2009-12-02 | 2017-10-03 | Adamas Pharmaceuticals Inc | Composições de amantadina e métodos de uso |
EP2744771B1 (de) * | 2011-08-19 | 2020-10-21 | The Trustees of Princeton University | Herstellung einer c-halogen-bindung |
GB201206984D0 (en) * | 2012-04-20 | 2012-06-06 | Univ Manchester | New therapeutic use |
US10154971B2 (en) | 2013-06-17 | 2018-12-18 | Adamas Pharma, Llc | Methods of administering amantadine |
RU2616255C1 (ru) * | 2016-05-16 | 2017-04-13 | Федеральное государственное бюджетное учреждение науки Новосибирский институт органической химии им. Н.Н. Ворожцова Сибирского отделения Российской академии наук (НИОХ СО РАН) | ПРИМЕНЕНИЕ (1S,3aR,4R,7aS)-N-(2,2,4,7a-ТЕТРАМЕТИЛОКТАГИДРО-1,4-ЭТАНОИНДЕН-3а-ИЛ)-АЦЕТАМИДА В КАЧЕСТВЕ ИНГИБИТОРА РЕПРОДУКЦИИ ВИРУСА ГРИППА |
US11548893B2 (en) | 2017-07-15 | 2023-01-10 | Arisan Therapeutics Inc. | Enantiomerically pure adamantane carboxamides for the treatment of filovirus infection |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2937211A (en) * | 1958-10-17 | 1960-05-17 | Du Pont | Chemical process |
US3352912A (en) * | 1963-07-24 | 1967-11-14 | Du Pont | Adamantanes and tricyclo[4. 3. 1. 1 3.8] undecanes |
US3391142A (en) * | 1966-02-09 | 1968-07-02 | Lilly Co Eli | Adamantyl secondary amines |
US4030994A (en) * | 1971-06-18 | 1977-06-21 | Merck & Co., Inc. | Substitutive fluorination of organic compounds |
GB1513135A (en) * | 1974-06-04 | 1978-06-07 | Res Inst For Med & Chem Inc | Fluorination process and fluoro steroids |
FR2514006A1 (fr) * | 1981-10-05 | 1983-04-08 | Nativelle Sa Ets | Acylamino-4 aza-1 adamantanes, procede pour leur preparation, et application en therapeutique |
ES506669A0 (es) * | 1981-10-29 | 1982-08-16 | Especialidades Farmaco Terape | Procedimiento para la obtencion de un nuevo compuesto deri- vado del acido p-clorofenoxiacetico |
US4829086A (en) * | 1984-03-14 | 1989-05-09 | Bodor Nicholas S | Soft β-adrenergic blocking agents |
FR2572399B1 (fr) * | 1984-10-31 | 1987-01-16 | Panmedica Sa | Nouveaux derives de l'adamantanamine, leurs procedes de preparation et medicaments les contenant |
LU85849A1 (fr) * | 1985-04-11 | 1986-11-05 | Cird | Derives benzonaphtaleniques,leur procede de preparation et leur application dans les domaines pharmaceutiques et cosmetiques |
US5482940A (en) * | 1988-05-24 | 1996-01-09 | American Home Products Corporation | Use of aryl- and heteroaryl piperazinyl carboxamides in the treatment of various central nervous system disorders |
JP3136206B2 (ja) * | 1991-10-22 | 2001-02-19 | 中外製薬株式会社 | ベンゾジオキサン誘導体 |
AU1884595A (en) * | 1994-04-29 | 1995-11-29 | Pfizer Inc. | Novel acyclic and cyclic amides as neurotransmitter release enhancers |
US5599998A (en) * | 1994-10-24 | 1997-02-04 | Iowa State University Research Foundation, Inc. | Method for the synthesis of adamantane amines |
-
1998
- 1998-03-24 DK DK98302196T patent/DK0870757T3/da active
- 1998-03-24 EP EP98302196A patent/EP0870757B1/de not_active Expired - Lifetime
- 1998-03-24 AT AT98302196T patent/ATE219044T1/de not_active IP Right Cessation
- 1998-03-24 DE DE69805909T patent/DE69805909T2/de not_active Expired - Fee Related
- 1998-03-24 PT PT98302196T patent/PT870757E/pt unknown
- 1998-03-24 ES ES98302196T patent/ES2175614T3/es not_active Expired - Lifetime
- 1998-04-08 BR BR9801157A patent/BR9801157A/pt not_active Application Discontinuation
- 1998-04-08 CA CA002234319A patent/CA2234319C/en not_active Expired - Fee Related
- 1998-04-09 US US09/057,694 patent/US6057364A/en not_active Expired - Fee Related
- 1998-04-09 JP JP10097707A patent/JP2951313B2/ja not_active Expired - Fee Related
-
1999
- 1999-04-27 JP JP11990499A patent/JP3338400B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2234319C (en) | 2003-03-25 |
JPH10298135A (ja) | 1998-11-10 |
EP0870757B1 (de) | 2002-06-12 |
US6057364A (en) | 2000-05-02 |
BR9801157A (pt) | 2000-03-21 |
ES2175614T3 (es) | 2002-11-16 |
JP2951313B2 (ja) | 1999-09-20 |
JP2000026367A (ja) | 2000-01-25 |
EP0870757A3 (de) | 2000-06-07 |
ATE219044T1 (de) | 2002-06-15 |
PT870757E (pt) | 2002-09-30 |
DK0870757T3 (da) | 2002-07-15 |
EP0870757A2 (de) | 1998-10-14 |
DE69805909D1 (de) | 2002-07-18 |
CA2234319A1 (en) | 1998-10-10 |
JP3338400B2 (ja) | 2002-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69805909D1 (de) | Fluorosubstituierte Adamantan-Derivate | |
ATE185792T1 (de) | Stilbenderivate und diese enthaltende pharmazeutische zusammensetzungen | |
CA2216796A1 (en) | Quinazoline derivatives | |
DK0598359T3 (da) | Hypoglykæmiske dihydrochalconderivater | |
PT87542A (pt) | Process for the preparation of a medicament based on indolone derivatives for the treatment of the parkinson disease | |
ES2087916T3 (es) | Derivado de pirimidina biciclico, metodo para producir el mismo, y preparacion farmaceutica que contiene el mismo como ingrediente activo. | |
PT802911E (pt) | Derivados de taxano hidrofobos | |
ES2147788T3 (es) | 3,4-diarilcromanos para el tratamiento de la dermatitis. | |
KR950032171A (ko) | 옥소피리디닐퀴녹살린 유도체 | |
DK0722724T3 (da) | Anvendelse af L-carnitin og dets derivater til nedsættelse af de toksiske virkninger af cyclosporin-A og andre immunosuppre | |
FI104071B1 (fi) | Analogiamenetelmä terapeuttisesti käyttökelpoisten 2,5-dihydro-2,5-diokso-1H-bents[b]atsepiinijohdannaisten valmistamiseksi | |
ATE264104T1 (de) | Immunmodulierende arzneimittelzusammenstellung | |
DE69030665D1 (de) | (1,2n) und (3,2n)-karbozyklische-2-amino-tetralinderivate | |
SE9302333D0 (sv) | New compounds | |
BG106180A (en) | Pharmaceutical composition containing sibutramine and orlistat | |
MX9300638A (es) | Derivados del acido aminobenzoico. | |
DE69635775D1 (de) | Medikament gegen pulmonale herzprobleme | |
EP0813866A3 (de) | Therapeutisches Mittel gegen Gelenkserkrankungen | |
EP0503079A4 (en) | Pyridazinone-substituted ethynylphenyl derivative and remedy for circulatory organ disease containing the same as active ingredient | |
PT1082116E (pt) | Utilizacao de derivados de 4-piperidinometanol no tratamento de desordens do neurodesenvolvimento | |
DE60213958D1 (de) | Aryl-n-cyanoguanidine derivate und deren verwendung | |
DE69611148D1 (de) | Pyrrolo(4,3,2-de)chinolin-Derivat | |
DK0749977T3 (da) | Nye 17-hydroxyiminoalkyl- og 17-hydroxyiminomethylalkenylcyclopentanperhydrophenanthrenderivater aktive på det cardiovaskul | |
KR920002139A (ko) | 뇌혈관 수축 치료제 | |
MX9605153A (es) | Agentes farmaceuticos para el tratamiento de enfermedades inflamatorias cronicas y agudas. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |